Verrica Pharmaceuticals Inc. (VRCA): Price and Financial Metrics
VRCA Price/Volume Stats
| Current price | $0.53 | 52-week high | $9.36 |
| Prev. close | $0.49 | 52-week low | $0.38 |
| Day low | $0.49 | Volume | 132,499 |
| Day high | $0.55 | Avg. volume | 359,218 |
| 50-day MA | $0.51 | Dividend yield | N/A |
| 200-day MA | $1.02 | Market Cap | 49.41M |
VRCA Stock Price Chart Interactive Chart >
Verrica Pharmaceuticals Inc. (VRCA) Company Bio
Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. The company is based in West Chester, Pennsylvania.
VRCA Price Returns
| 1-mo | 13.01% |
| 3-mo | -14.71% |
| 6-mo | -55.46% |
| 1-year | -93.77% |
| 3-year | -76.65% |
| 5-year | -95.58% |
| YTD | -24.29% |
| 2024 | -90.44% |
| 2023 | 166.18% |
| 2022 | -69.98% |
| 2021 | -20.42% |
| 2020 | -27.56% |
Loading social stream, please wait...